NasdaqCM - Nasdaq Real Time Price USD
Cue Biopharma, Inc. (CUE)
0.7797
+0.0117
+(1.52%)
At close: May 9 at 4:00:02 PM EDT
0.7797
0.00
(0.00%)
After hours: May 9 at 4:00:13 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 2 |
| Avg. Estimate | -0.15 | -0.14 | -0.57 | -0.61 |
| Low Estimate | -0.18 | -0.15 | -0.63 | -0.66 |
| High Estimate | -0.13 | -0.13 | -0.53 | -0.56 |
| Year Ago EPS | -0.25 | -0.2 | -0.72 | -0.57 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | 1.27M | 1.6M | 6.62M | 6.24M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 2M | 2.79M | 9.75M | 10M |
| Year Ago Sales | 1.72M | 2.66M | 9.29M | 6.62M |
| Sales Growth (year/est) | -26.17% | -39.92% | -28.77% | -5.72% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.29 | -0.28 | -0.19 | -0.14 |
| EPS Actual | -0.25 | -0.2 | -0.17 | -0.13 |
| Difference | 0.04 | 0.08 | 0.02 | 0.02 |
| Surprise % | 14.53% | 28.57% | 10.03% | 11.72% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.14 | -0.57 | -0.61 |
| 7 Days Ago | -0.12 | -0.12 | -0.46 | -0.49 |
| 30 Days Ago | -0.15 | -0.14 | -0.57 | -0.46 |
| 60 Days Ago | -0.15 | -0.14 | -0.57 | -0.46 |
| 90 Days Ago | -0.15 | -0.14 | -0.57 | -0.46 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CUE | 38.67% | 30.00% | 20.78% | -6.40% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 4/2/2025 |
| Maintains | Stifel: Buy to Buy | 8/20/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 7/26/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 7/26/2024 |
| Maintains | Stifel: Buy to Buy | 4/9/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 4/9/2024 |
Related Tickers
RNTX Rein Therapeutics Inc.
1.7600
+1.15%
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
INAB IN8bio, Inc.
0.1574
-6.25%
RNXT RenovoRx, Inc.
1.0600
+1.92%
APS.TO Aptose Biosciences Inc.
2.2100
-0.45%
COYA Coya Therapeutics, Inc.
6.05
-2.58%
PHRRF PharmaTher Holdings Ltd.
0.1570
+3.09%
PBLA Panbela Therapeutics, Inc.
0.3110
+0.32%
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%
GANX Gain Therapeutics, Inc.
1.9400
-4.20%